M&T Bank’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-37,487
| Closed | -$209K | – | 1551 |
|
|
2024
Q4 | $209K | Buy |
37,487
+18,639
| +99% | +$104K | ﹤0.01% | 1515 |
|
|
2024
Q3 | $204K | Sell |
18,848
-10,161
| -35% | -$110K | ﹤0.01% | 1514 |
|
|
2024
Q2 | $609K | Sell |
29,009
-334
| -1% | -$7.01K | ﹤0.01% | 1039 |
|
|
2024
Q1 | $935K | Sell |
29,343
-10,168
| -26% | -$324K | ﹤0.01% | 906 |
|
|
2023
Q4 | $800K | Buy |
39,511
+30
| +0.1% | +$608 | ﹤0.01% | 952 |
|
|
2023
Q3 | $503K | Buy |
39,481
+10,667
| +37% | +$136K | ﹤0.01% | 1080 |
|
|
2023
Q2 | $520K | Hold |
28,814
| – | – | ﹤0.01% | 1103 |
|
|
2023
Q1 | $496K | Buy |
28,814
+5,270
| +22% | +$90.7K | ﹤0.01% | 1120 |
|
|
2022
Q4 | $522K | Sell |
23,544
-34,712
| -60% | -$770K | ﹤0.01% | 1086 |
|
|
2022
Q3 | $468K | Buy |
58,256
+7,148
| +14% | +$57.4K | ﹤0.01% | 1115 |
|
|
2022
Q2 | $356K | Buy |
51,108
+24,236
| +90% | +$169K | ﹤0.01% | 1120 |
|
|
2022
Q1 | $406K | Buy |
26,872
+14,552
| +118% | +$220K | ﹤0.01% | 1078 |
|
|
2021
Q4 | $270K | Buy |
12,320
+672
| +6% | +$14.7K | ﹤0.01% | 1295 |
|
|
2021
Q3 | $314K | Buy |
11,648
+1,153
| +11% | +$31.1K | ﹤0.01% | 1214 |
|
|
2021
Q2 | $253K | Hold |
10,495
| – | – | ﹤0.01% | 1343 |
|
|
2021
Q1 | $455K | Hold |
10,495
| – | – | ﹤0.01% | 1044 |
|
|
2020
Q4 | $435K | Buy |
+10,495
| New | +$435K | ﹤0.01% | 1127 |
|